Skip to main content

AstraZeneca PLC

AZN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000901832

In the last 90 days, AstraZeneca PLC insiders filed 1 open-market purchase and 0 sales; 1,509 institutions reported holding it in 13F filings for Q2 2026, worth $207.5B in total; no superinvestor holds it.

Key figures

Insider buysLast 90 days, $3.25K in total
1
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +143 vs. previous quarter
1,509
13F valueReported value at the end of Q2 2026
$207.5B
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding AZN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding AZN at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by AstraZeneca PLC insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 11, 2026 (view filing)4:05 PM ETAug 834 daysLateSharma ManiSee RemarksPPurchase+20.23$160.57+$3.25K+0.1%19.3K after
May 22, 2026 (view filing)May 202 daysSharma ManiSee RemarksSSale−11.9K$185.78−$2.21M−38.2%19.3K after

Top 10 13F holders, Q2 2026

The largest institutional positions in AstraZeneca PLC at the end of Q2 2026; share changes are against Q1 2026.

See all 1,509 holders
Institutions holding AZN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Evelyn Partners Group Ltd2,237,205$41.5B88.60%+2,237,205New
Banque Cantonale Vaudoise60,462$11.3B1.57%+60,462New
Investor AB51,587,810$9.78B67.92%00.0%Unchanged
Vanguard Capital Management LLC45,386,190$8.47B0.18%+346,048+0.8%Added
Capital International Investors34,576,070$6.49B1.34%+183,057+0.5%Added
Norges Bank33,864,172$6.33B0.63%+33,864,172New
Capital World Investors30,075,134$5.63B0.66%+1,810,554+6.4%Added
FMR LLC28,895,264$5.42B0.24%−706,460−2.4%Reduced
Wellington Management Group LLP28,537,243$5.36B0.92%+4,786,158+20.2%Added
Legal & General Group Plc25,750,245$4.82B1.00%−99,733−0.4%Reduced